Myocardial protection of MCI-186 in rabbit ischemia-reperfusion

Life Sciences

Volumn 71, Issue 19, 2002, Pages 2249-2255

  Wu, Tai Wing ^a   Zeng, Ling Hua ^a   Wu, Jun ^a   Fung, Kwok Pui ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Heart; Ischemia reperfusion; MCI 186; MDA

Indexed keywords

MALONALDEHYDE; NORPHENAZONE;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFICACY; HEART MUSCLE ISCHEMIA; IN VIVO STUDY; LIGATION; NONHUMAN; RABBIT; REDUCTION; REPERFUSION INJURY; RISK FACTOR;

ANIMALS; ANTIPYRINE; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; FREE RADICAL SCAVENGERS; MALONDIALDEHYDE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NECROSIS; RABBITS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0037183707     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)01965-3     Document Type: Article

References (13)

1. Watanabe T., Egawa M. Effects of an antistroke agent MCI-186 on cerebral arachidonate cascade. Journal of Pharmacology and Experimental Therapeutics. 271(3):1994;1624-1629.
2. Watanabe T., Morita I., Nishi H., Murota S. Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukotrienes and Essential Fatty Acids. 33:1998;81-87.
3. Oishi R., Itoh Y., Nishibori M., Watanabe T., Nishi H., Saeki K. Effect of MCI-186 on Ischemia-Induced changes in monoamine metabolism in rat brain. Stroke. 20(11):1989;1557-1564.
4. Minhaz U., Tanaka M., Tsukamoto H., Watanabe K., Koidee S., Shohtsu A., Nakazawa H. Effect of MCI-186 on Postischemic Reperfusion Injury in Isolated Rat Heart. Free Rad. Res. 24(5):1996;361-367.
5. Yanagisawa A., Miyagawa M., Ishikawa K., Murota S. Cardioprotective Effect of MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one) during Acute Ischemia-Reperfusion Injury in Rats. International Journal of Angiology. 3:1994;12-15.
6. Wu T.W., Zeng L.H., Wu J., Fung K.P. MCI 186: further histochemical and biochemical evidence of neuroprotection. Life Sciences. 67:2000;2387-2392.
7. Cross C.E., Halliwell B., Borish E.T., Pryor W.A., Ames B.N., Saul R.L., McCord J.M., Harman D. Oxygen radicals and human disease. Annals of Internal Medicine. 107(4):1987;526-545.
8. Doroshow J.H., Locker G.Y., Myers C.E. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. Journal of Clinical Investigation. 65(1):1980;128-135.
9. Downey J.M., Miura T., Eddy L.J., Chambers D.E., Mellert T., Hearse D.J., Yellon D.M. Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. Journal of Molecular and Cellular Cardiology. 19(11):1987;1053-1060.
10. Wu T.W., Wu J., Zeng L.H., Sugiyama H., Mickle D.A., Au J.X. Reduction of experimental myocardial infarct size by infusion of lactosylphenyl Trolox. Cardiovascular Research. 27:1993;736-739.
11. Wu T.W., Zeng L.H., Fung K.P., Wu J., Pang H., Grey A.A., Weisel R.D., Wang J.Y. Effect of sodium Tanshinone IIA sulfonate in the rabbit myocardium and human cardiomyocytes and vascular endothelial cells. Biochemical Pharmacology. 46:1993;2327-2333.
12. Conti M., Morand P.C., Levillain P., Lemonnier A. Improved fluorometric determination of malonaldehyde. Clinical Chemistry. 37(7):1991;1273-1275.
13. Brady A.J., Williams F.M., Williams T.J. Inflammatory injury in myocardial ischaemia. Clinical Science. 83(5):1992;511-518.